Stocktoria
Quanterix Corp QTRX
Nasdaq · XNAS · stock · Laboratory Analytical Instruments · website · IPO 2017-12-07
Quanterix Corp statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 46.8% | 60.5% | 60.7% | 43.0% | 55.8% |
| Operating margin | -90.4% | -38.3% | -37.6% | -98.8% | -53.0% |
| Net margin | -77.1% | -28.0% | -23.2% | -94.4% | -52.2% |
| FCF margin | -57.5% | -28.0% | -18.5% | -57.1% | -55.6% |
| Return on assets | -25.6% | -9.5% | -6.6% | -22.9% | -11.5% |
| Return on equity | -36.2% | -11.7% | -8.1% | -27.8% | -13.0% |
| Current ratio | 2.84 | 8.66 | 9.80 | 12.32 | 12.14 |
| Revenue growth | 1.1% | 12.3% | 16.0% | -4.6% | 28.0% |
Source: SEC EDGAR filings · CIK 0001503274 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.